Impaired blood-brain/spinal cord barrier in ALS patients

Brain Research

Volumn 1469, Issue , 2012, Pages 114-128

  Garbuzova Davis, Svitlana ^a   Hernandez Ontiveros, Diana G ^a   Rodrigues, Maria C O ^a,c   Haller, Edward ^b   Frisina Deyo, Aric ^a   Mirtyl, Santhia ^a   Sallot, Sebastian ^a   Saporta, Samuel ^a   Borlongan, Cesario V ^a   Sanberg, Paul R ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Amyotrophic lateral sclerosis; Blood brain spinal cord barrier; Impairment; Patients

Indexed keywords

CD31 ANTIGEN; COLLAGEN TYPE 4; ENDOGLIN; FIBRIN;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BLOOD BRAIN BARRIER; BLOOD SPINAL CORD BARRIER; CONTROLLED STUDY; GRAY MATTER; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; WHITE MATTER;

AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; BLOOD-BRAIN BARRIER; DISEASE PROGRESSION; ENDOTHELIAL CELLS; FEMALE; HUMANS; MALE; MEDULLA OBLONGATA; MIDDLE AGED; SPINAL CORD; TIGHT JUNCTIONS;

EID: 84864775702     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2012.05.056     Document Type: Article

References (41)

1. R.W. Arhart A possible haemodynamic mechanism for amyotrophic lateral sclerosis Med. Hypotheses 75 2010 341 346
2. P. Ballabh, A. Braun, and M. Nedergaard The blood-brain barrier: an overview: structure, regulation, and clinical implications Neurobiol. Dis. 16 2004 1 13 (Pubitemid 38569790)
3. D.J. Begley ABC transporters and the blood-brain barrier Curr. Pharm. Des. 10 2004 1295 1312 (Pubitemid 38559749)
4. D.J. Begley, and M.W. Brightman Structural and functional aspects of the blood-brain barrier Prog. Drug Res. 61 2003 39 78 (Pubitemid 37187402)
5. W. Beuche, M. Yushchenko, M. Mäder, M. Maliszewska, K. Felgenhauer, and F. Weber Matrix metalloproteinase-9 is elevated in serum of patients with amyotrophic lateral sclerosis Neuroreport 11 2000 3419 3422
6. K.E. Biron, D.L. Dickstein, R. Gopaul, and W.A. Jeffries Amyloid triggers extensive cerebral angiogenesis causing blood brain barrier permeability and hypervascularity in Alzheimer's disease PLoS One 6 2011 e23789
7. L.I. Bruijn, T.M. Miller, and D.W. Cleveland Unraveling the mechanisms involved in motor neuron degeneration in ALS Annu. Rev. Neurosci. 27 2004 723 749 (Pubitemid 39050419)
8. E. Candelario-Jalil, Y. Yang, and G.A. Rosenberg Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia Neuroscience 158 2009 983 994
9. L. Claudio Ultrastructural features of the blood-brain barrier in biopsy tissue from Alzheimer's disease patients Acta Neuropathol. 91 1996 6 14
10. D.W. Cleveland, and J.D. Rothstein From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS Nat. Rev. Neurosci. 2 2001 806 819 (Pubitemid 33674062)
11. R. Dermietzel, and D. Krause Molecular anatomy of the blood-brain barrier as defined by immunocytochemistry Int. Rev. Cytol. 127 1991 57 109
12. L. Fang, M. Teuchert, F. Huber-Abel, D. Schattauer, C. Hendrich, J. Dorst, H. Zettlmeissel, M. Wlaschek, K. Scharffetter-Kochanek, T. Kapfer, H. Tumani, A.C. Ludolph, and J. Brettschneider MMP-2 and MMP-9 are elevated in spinal cord and skin in a mouse model of ALS J. Neurol. Sci. 294 2010 51 56
13. S. Fukuda, C.A. Fini, T. Mabuchi, J.A. Koziol, L.L. Eggleston Jr., and G.J. del Zoppo Focal cerebral ischemia induces active proteases that degrade microvascular matrix Stroke 35 2004 998 1004 (Pubitemid 38419817)
14. S. Garbuzova-Davis, E. Haller, S. Saporta, I. Kolomey, S.V. Nicosia, and P.R. Sanberg Ultrastructure of blood-brain barrier and blood-spinal cord barrier in SOD1 mice modeling ALS Brain Res. 1157 2007 126 137 (Pubitemid 46935078)
15. S. Garbuzova-Davis, M.C.O. Rodrigues, D.G. Hernandez-Ontiveros, M.K. Louis, A.E. Willing, C.V. Borlongan, and P.R. Sanberg Amyotrophic lateral sclerosis: a neurovascular disease Brain Res. 1398 2011 113 125
16. S. Garbuzova-Davis, S. Saporta, E. Haller, I. Kolomey, S.P. Bennett, H. Potter, and P.R. Sanberg Evidence of compromised blood-spinal cord barrier in early and late symptomatic SOD1 mice modeling ALS PLoS One 2 2007 e1205
17. S. Garbuzova-Davis, R.L. Woods, M.K. Louis, T.A. Zesiewicz, N. Kuzmin-Nichols, K.L. Sullivan, A.M. Miller, D.G. Hernandez-Ontiveros, and P.R. Sanberg Reduction of circulating endothelial cells in peripheral blood of ALS patients PLoS One 5 2010 e10614
18. Y. Gasche, P.M Soccal, M. Kanemitsu, and J.-C. Copin Matrix metalloproteinases and diseases of the central nervous system with a special emphasis on ischemic brain Front. Biosci. 11 2006 1289 1301 (Pubitemid 43253422)
19. J.S. Henkel, D.R. Beers, S. Wen, R. Bowser, and S.H. Appel Decreased mRNA expression of tight junction proteins in lumbar spinal cords of patients with ALS Neurology 72 2009 1614 1616
20. K.K. Hirschi, and P.A. D'Amore Pericytes in the microvasculature Cardiovasc. Res. 32 1996 687 698 (Pubitemid 26332308)
21. J. Iłzecka Cerebrospinal fluid vascular endothelial growth factor in patients with amyotrophic lateral sclerosis Clin. Neurol. Neurosurg. 106 2004 289 293 (Pubitemid 39024628)
22. M.E. Kutcher, and I.M. Herman The pericyte: cellular regulator of microvascular blood flow Microvasc. Res. 77 2009 235 246
23. S. Lorenzl, D.S. Albers, P.A. LeWitt, J.W. Chirichigno, S.L. Hilgenberg, M.E. Cudkowicz, and M.F. Beal Tissue inhibitors of matrix metalloproteinases are elevated in cerebrospinal fluid of neurodegenerative diseases J. Neurol. Sci. 207 2003 71 76 (Pubitemid 36292132)
24. S. Lorenzl, G. De Pasquale, A.Z. Segal, and M.F. Beal Dysregulation of the levels of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in the early phase of cerebral ischemia Stroke 34 2003 e37 38
25. K. Miyazaki, Y. Ohta, M. Nagai, N. Morimoto, T. Kurata, Y. Takehisa, Y. Ikeda, T. Matsuura, and K. Abe Disruption of neurovascular unit prior to motor neuron degeneration in amyotrophic lateral sclerosis J. Neurosci. Res. 89 2011 718 728
26. C. Nicaise, D. Mitrecic, P. Demetter, R. De Decker, M. Authelet, A. Boom, and R. Pochet Impaired blood-brain and blood-spinal cord barriers in mutant SOD1-linked ALS rat Brain Res. 1301 2009 152 162
27. C. Nicaise, M.S. Soyfoo, M. Authelet, R. De Decker, D. Bataveljic, C. Delporte, and R. Pochet Aquaporin-4 overexpression in rat ALS model Anat. Rec. (Hoboken) 292 2009 207 213
28. I. Niebroj-Dobosz, P. Janik, B. Sokolowska, and H. Kwiecinski Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis Eur. J. Neurol. 17 2010 226 231
29. S. Ono, T. Imai, S. Munakata, K. Takahashi, F. Kanda, K. Hashimoto, T. Yamano, N. Shimizu, K. Nagao, and M. Yamauchi Collagen abnormalities in the spinal cord from patients with amyotrophic lateral sclerosis J. Neurol. Sci. 160 1998 140 147 (Pubitemid 28522538)
30. W.M. Pardridge Blood-brain barrier biology and methodology J. Neurovirol. 5 1999 556 569 (Pubitemid 30032082)
31. A. Pozzi, and R. Zent Regulation of endothelial cell functions by basement membrane- and arachidonic acid-derived products Rev. Syst. Biol. Med. 1 2009 254 272
32. D.R. Rosen, T. Siddique, D. Patterson, D.A. Figlewicz, P. Sapp, A. Hentati, D. Donaldson, J. Goto, J.P. O'Regan, and H.X. Deng Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis Nature 362 1993 59 62 (Pubitemid 23087289)
33. G.A. Rosenberg Matrix metalloproteinases in neuroinflammation Glia 39 2002 279 291
34. J.D. Rothstein Current hypotheses for the underlying biology of amyotrophic lateral sclerosis Ann. Neurol. 65 1 2009 S3 9
35. R.R. Rule, N. Schuff, R.G. Miller, and M.W. Weiner Gray matter perfusion correlates with disease severity in ALS Neurology 74 2010 821 827
36. J.T. Rutka, G. Apodaca, R. Stern, and M. Rosenblum The extracellular matrix of the central and peripheral nervous systems: structure and function J. Neurosurg. 69 1988 155 170
37. C.P.W. Soon, P.J. Crouch, B.J. Turner, C.A. McLean, K.M. Laughton, J.D. Atkin, C.L. Masters, A.R. White, and Q.-X. Li Serum matrix metalloproteinase-9 activity is dysregulated with disease progression in the mutant SOD1 transgenic mice Neuromuscul. Disord. 20 2010 260 266
38. M.J. Strong, S. Kesavapany, and H.C. Pant The pathobiology of amyotrophic lateral sclerosis: a proteinopathy? J. Neuropathol. Exp. Neurol. 64 2005 649 664 (Pubitemid 41177106)
39. D. Vestweber VE-cadherin: the major endothelial adhesion molecule controlling cellular junctions and blood vessel formation Arterioscler. Thromb. Vasc. Biol. 28 2008 223 232 (Pubitemid 351161193)
40. A.W. Vorbrodt, and D.H. Dobrogowska Molecular anatomy of intercellular junctions in brain endothelial and epithelial barriers: electron microscopist's view Brain Res. Brain Res. Rev. 42 2003 221 242 (Pubitemid 36645239)
41. Z. Zhong, R. Deane, Z. Ali, M. Parisi, Y. Shapovalov, M.K. O'Banion, K. Stojanovic, A. Sagare, S. Boillee, D.W. Cleveland, and B.V. Zlokovic ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration Nat. Neurosci. 11 2008 420 422 (Pubitemid 351441888)